mLabs  SARS-CoV-2 IgG/IgM Assay

 

COVID-19 Antibody Test

Rapid Results in 4-8 Minutes

 

The mLabs SARS-CoV-2 IgG and IgM assay is a fluorescent microparticle immunoassay intended for the qualitative detection of the total IgC and IgM antibodies to SARS-CoV-2 in human whole blood, and plasma.

All samples were collected from individuals who were confirmed as positive or negative for the SARS-CoV-2 virus by various (FDA-authorized) PCR tests.

Features:

  • Easy-to-use touchscreen operation

  • Fast: qualitative results in 4-8 minutes

  • Stable: the signal is stable after testing and remains constant for at least 30 minutes

  • Patented microfluidic technology enables highly precise and reliable qualitative fluorescence immunoassay testing

 

COVID-19 Antibody Test Resources:

Datasheet

Instructions for Use (OUTSIDE OF USA)

mLabs SARS-CoV-2 IgG/IgM assay is FDA-submitted and EUA-submitted, and in review.

 

 

 

To contact Micropoint to find out more or to purchase mLabs SARS-CoV-2 IgG/IgM assay, please email: info@micropointbio.com.

®

 

 

U.S. Headquarters

 

Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States

 

T:+1 (408) 588-1682
F:+1 (408) 588-1620

 

 

European Office

 

Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble

France 

 

T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office

 

Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong

China

 

T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.